| Efficacy of MEK inhibition in patients with histiocytic neoplasms EL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn, M Ki, L Bitner, ... Nature 567 (7749), 521-524, 2019 | 274 | 2019 |
| A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease E Mass, CE Jacome-Galarza, T Blank, T Lazarov, BH Durham, N Ozkaya, ... Nature 549 (7672), 389-393, 2017 | 185 | 2017 |
| The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort N Ozkaya, MK Rosenblum, BH Durham, JD Pichardo, O Abdel-Wahab, ... Modern Pathology 31 (4), 581-597, 2018 | 135 | 2018 |
| High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis M Papo, EL Diamond, F Cohen-Aubart, JF Emile, D Roos-Weil, N Gupta, ... Blood, The Journal of the American Society of Hematology 130 (8), 1007-1013, 2017 | 116 | 2017 |
| Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells BH Durham, D Roos-Weil, C Baillou, F Cohen-Aubart, A Yoshimi, ... Blood, The Journal of the American Society of Hematology 130 (2), 176-180, 2017 | 113 | 2017 |
| Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms NE Lewis, K Petrova-Drus, S Huet, ZD Epstein-Peterson, Q Gao, ... Blood advances 4 (10), 2261-2271, 2020 | 76 | 2020 |
| T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma P Ghione, P Faruque, N Mehta-Shah, V Seshan, N Ozkaya, S Bhaskar, ... Blood advances 4 (19), 4640-4647, 2020 | 65 | 2020 |
| Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1 J Razanamahery, EL Diamond, F Cohen-Aubart, KH Plate, G Lourida, ... Haematologica 105 (1), e5, 2020 | 49 | 2020 |
| Single-agent dabrafenib for BRAFV600E-mutated histiocytosis A Bhatia, G Ulaner, R Rampal, DM Hyman, O Abdel-Wahab, BH Durham, ... Haematologica 103 (4), e177, 2018 | 47 | 2018 |
| Neurologic and oncologic features of Erdheim–Chester disease: a 30-patient series A Bhatia, V Hatzoglou, G Ulaner, R Rampal, DM Hyman, O Abdel-Wahab, ... Neuro-oncology 22 (7), 979-992, 2020 | 45 | 2020 |
| Neurological manifestations of Erdheim–Chester disease LC Boyd, KJ O’Brien, N Ozkaya, T Lehky, A Meoded, BR Gochuico, ... Annals of clinical and translational neurology 7 (4), 497-506, 2020 | 30 | 2020 |
| Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease EL Diamond, O Abdel-Wahab, BH Durham, A Dogan, N Ozkaya, L Brody, ... Blood, The Journal of the American Society of Hematology 128 (14), 1896-1898, 2016 | 28 | 2016 |
| Identification and targeting of kinase alterations in histiocytic neoplasms N Ozkaya, A Dogan, O Abdel-Wahab Hematology/Oncology Clinics 31 (4), 705-719, 2017 | 21 | 2017 |
| Peripheral T-cell lymphoma–are we making progress? N Khan, N Ozkaya, A Moskowitz, A Dogan, S Horwitz Best Practice & Research Clinical Haematology 31 (3), 306-314, 2018 | 14 | 2018 |
| Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma M Yabe, Q Gao, N Ozkaya, S Huet, N Lewis, JD Pichardo, AJ Moskowitz, ... Blood cancer journal 10 (3), 32, 2020 | 13 | 2020 |
| Natural history study of patients with familial platelet disorder with associated myeloid malignancy L Cunningham, M Merguerian, KR Calvo, J Davis, NT Deuitch, ... Blood 142 (25), 2146-2158, 2023 | 8 | 2023 |
| Discrepancies in lymphoma diagnosis over the years: a 13-year experience in a tertiary center N Özkaya, N Başsüllü, AS Demiröz, N Tüzüner Turkish Journal of Hematology 34 (1), 81, 2017 | 7 | 2017 |
| Romidepsin activity in T follicular helper (TFH)-phenotype PTCL versus non TFH treated on the same clinical trials. P Ghione, N Ozkaya, P Faruque, N Mehta-Shah, MA Lunning, J Ruan, ... Journal of Clinical Oncology 36 (15_suppl), 7509-7509, 2018 | 6 | 2018 |
| A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies BC Lee, Y Zhou, E Bresciani, N Ozkaya, A Dulau-Florea, B Carrington, ... Blood 141 (3), 231-237, 2023 | 4 | 2023 |
| Novel insights into the early histopathogenesis of immunodeficiency‐associated Burkitt lymphoma: a case report of Burkitt microlymphoma arising within HIV lymphadenitis D Park, N Ozkaya, A Hariharan Histopathology 69 (3), 516-521, 2016 | 4 | 2016 |
Jean-François Emileuniversité de Versailles SQY, UVSQ, APHPVerified email at uvsq.fr
